作者: Marco Arrese , Juan Pablo Arab , Juan Pablo Arancibia , Roberto Candia , Arnoldo Riquelme
DOI: 10.1016/B978-0-12-385083-6.00023-1
关键词: Steatohepatitis 、 Fatty liver 、 Gastroenterology 、 Metabolic syndrome 、 Internal medicine 、 Cirrhosis 、 Medicine 、 Liver disease 、 Diabetes mellitus 、 Type 2 Diabetes Mellitus 、 Hepatic Complication
摘要: : Type 2 diabetes mellitus (T2DM) is strongly associated with liver fat accumulation leading to the so-called non-alcoholic fatty disease (NAFLD). In last two decades, it has been recognized that a proportion of patients NAFLD may develop progressive form called steatohepatitis (NASH) which lead cirrhosis, end-stage complications and risk developing hepatocellular carcinoma. now considered hepatic manifestation metabolic syndrome T2DM being clear factor for NASH cirrhosis development. Here, current concepts on its association are reviewed. Current knowledge suggests exhibit an increased awareness should be enhanced among health providers involved in diabetes. Finally, screening disorders part routine evaluation T2DM.